Respiratory toxicity of persulphate salts and their adverse effects on airways in hairdressers: a systematic review.
Hair bleach
Hairdressing apprentices
Lung function
Occupational asthma
Occupational rhinitis
Specific inhalatory challenge
Journal
International archives of occupational and environmental health
ISSN: 1432-1246
Titre abrégé: Int Arch Occup Environ Health
Pays: Germany
ID NLM: 7512134
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
31
12
2021
accepted:
01
03
2022
pubmed:
23
3
2022
medline:
24
9
2022
entrez:
22
3
2022
Statut:
ppublish
Résumé
To review the literature on respiratory effects of persulfate salts (PS) or hair bleaches in hairdressers and animal models exploring mechanisms behind PS-induced asthma. A systematic review according to the PRISMA guidelines was performed. Studies published from 2000 to July 2021 that fulfilled predefined eligibility criteria were retrieved. Data were not quantitatively synthesized due to the heterogeneity of study designs, outcomes and methods. Forty-two articles were included. PS are indicated as the main cause of occupational rhinitis and asthma in hairdressers, and one of the leading causes of occupational asthma in some European countries. Bleaching products are indicated as the most important factor for development of respiratory symptoms, lung function decline, and leaving the hairdressing profession. Risk estimates from a good quality prospective study showed up to 3.9 times higher risk for wheezing and breathlessness in hairdressers aged ≥ 40 years than in matched controls, and 20 times higher risk in hairdressers to develop respiratory symptoms from exposure to bleaching powder than controls. Pathophysiological mechanisms of the respiratory response to PS are not yet fully elucidated, but may include non-specific and specific immune responses. Hairdressing is associated with a wide spectrum of respiratory adverse effects, of which bleaching products were indicated as the most hazardous. Preventive measures for reducing inhalatory exposure to PS in hair salons should be re-evaluated, including adopting occupational exposure limits at EU level, and encouraging use of safer bleach formulations. CRD42021238118.
Identifiants
pubmed: 35316371
doi: 10.1007/s00420-022-01852-w
pii: 10.1007/s00420-022-01852-w
pmc: PMC9489562
doi:
Substances chimiques
Powders
0
Salts
0
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1679-1702Informations de copyright
© 2022. The Author(s).
Références
Occup Med (Lond). 2016 Oct;66(7):584-5
pubmed: 27036150
G Ital Med Lav Ergon. 2020 Sep;42(3):153-159
pubmed: 33119975
J Occup Environ Med. 2003 Nov;45(11):1201-6
pubmed: 14610402
Curr Opin Allergy Clin Immunol. 2008 Apr;8(2):115-9
pubmed: 18317018
Contact Dermatitis. 2012 Jun;66(6):317-22
pubmed: 22568838
Clin Transl Allergy. 2016 Jul 21;6:26
pubmed: 27446529
Respiration. 2010;79(5):411-9
pubmed: 19923787
Respir Care. 2010 Jul;55(7):895-900
pubmed: 20587102
Int J Toxicol. 2001;20 Suppl 3:7-21
pubmed: 11766134
Int Arch Occup Environ Health. 2009 Nov;82(10):1261-6
pubmed: 19333615
Int Arch Occup Environ Health. 2014 Jan;87(1):61-71
pubmed: 23263693
Int J Immunopathol Pharmacol. 2004 May-Aug;17(2 Suppl):77-82
pubmed: 15345196
Allergy. 2017 Nov;72(11):1720-1727
pubmed: 28439933
Eur Ann Allergy Clin Immunol. 2014 Jan;46(1):26-9
pubmed: 24702870
J Occup Health. 2016 Sep 30;58(5):470-476
pubmed: 27488042
Int J Nurs Stud. 2009 Apr;46(4):529-46
pubmed: 19233357
Inhal Toxicol. 2001 Nov;13(11):1033-45
pubmed: 11696872
Contact Dermatitis. 2006 Jan;54(1):62-3
pubmed: 16426299
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
Adv Exp Med Biol. 2015;861:85-91
pubmed: 26022895
BMJ Open. 2021 Dec 6;11(12):e050612
pubmed: 34872997
Thorax. 2010 Mar;65(3):252-7
pubmed: 20335296
Am J Ind Med. 2011 Jul;54(7):565-8
pubmed: 21394743
J Proteome Res. 2010 Nov 5;9(11):5620-8
pubmed: 20815409
J Environ Health. ;79(9):8-14
pubmed: 29154510
Clinics (Sao Paulo). 2008 Feb;63(1):149-50
pubmed: 18297222
Allergy Asthma Clin Immunol. 2016 May 24;12:26
pubmed: 27222656
Chest. 2005 Nov;128(5):3590-8
pubmed: 16304318
Occup Environ Med. 1996 Jun;53(6):422-6
pubmed: 8758039
Int J Tuberc Lung Dis. 2012 Jan;16(1):138-9
pubmed: 22236860
Occup Environ Med. 2001 Dec;58(12):780-5
pubmed: 11706144
J Community Health. 2015 Aug;40(4):670-9
pubmed: 25663369
Occup Environ Med. 2003 Nov;60(11):831-40
pubmed: 14573713
BMJ Open. 2015 Oct 15;5(10):e007857
pubmed: 26474935
Dermatitis. 2012 Nov-Dec;23(6):284-7
pubmed: 23169211
Chest. 2003 Jun;123(6):2124-9
pubmed: 12796198
Occup Environ Med. 2006 Apr;63(4):255-60
pubmed: 16556745
Occup Environ Med. 2002 Feb;59(2):119-23
pubmed: 11850555
PLoS One. 2014 Oct 10;9(10):e109000
pubmed: 25303285
Am J Ind Med. 2014 Dec;57(12):1368-76
pubmed: 25351556
Occup Environ Med. 2003 Feb;60(2):136-41
pubmed: 12554842
Int Arch Occup Environ Health. 2009 May;82(6):771-7
pubmed: 19048274
Allergy. 2010 Jun 1;65(6):784-90
pubmed: 20015325
Int Forum Allergy Rhinol. 2017 Jan;7(1):43-49
pubmed: 27513701
Allergy Asthma Immunol Res. 2020 Jul;12(4):579-598
pubmed: 32400126
Am J Rhinol. 2008 Jan-Feb;22(1):38-46
pubmed: 18284858
Eur Respir J. 2002 Jan;19(1):84-9
pubmed: 11843332
Occup Environ Med. 2004 Oct;61(10):861-6
pubmed: 15377773
Contact Dermatitis. 2009 Dec;61(6):356-7
pubmed: 20059501